Health Condition 1: null- Patients with ASA grade I and II, aged 20-45 years , of both sexes scheduled for laproscopic intervention
Conditions
Interventions
Intervention1: DEXMEDITOMIDINE: The grouping is as follows
INTERVENTIONAL GROUP :DEXMEDITOMIDINE GROUP
CONTROL GROUP : LIDOCAINE GROUP
Intervention2: DEXMEDITOMIDINE: All patients in this group will
Sponsors
DEPARTMENT OF ANAESTHESIA
DR PARUKUTTY AMMA
Eligibility
Inclusion criteria
Inclusion criteria: Patients with ASA grade I and II, aged 20-45 year , of both sexes scheduled for laproscopic surgery.
Exclusion criteria
Exclusion criteria: Patients who donot give consent. Patients with heart block, hypertensive patients on β blockers, morbid obesity, Pregnant women & history of psychiatric disorder are excluded from the study. Patients with diabetes and renal disease is not included in the study. Clarithromycin, ciprofloxacine, itraconazole, ketaconazole will not be included in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Attenuation of stress response will be measured by taking the difference between heart rate, systolic blood pressure, diastolic blood pressure of two groupsTimepoint: The parameters such as heart rate, systolic blood pressure, diastolic blood pressure, mean arterial blood pressure, respiratory rate, oxygen saturation will be recorded during infusion/ injection ,preinduction,induction, & 0 min, 1 min, 5 min after intubation | — |
Secondary
| Measure | Time frame |
|---|---|
| Any side effects such as hypotension or bradycardiaTimepoint: Any side effects such as hypotension or bradycardia | — |
Countries
India
Contacts
Public ContactDRSREEJITHH
DR SMCSI MEDICAL COLLEGE
Outcome results
None listed